Vitamin D, cardiovascular disease, . . . and other stories
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4411 (Published 04 July 2019) Cite this as: BMJ 2019;366:l4411Vitamin D supplements
Controversy over the value of vitamin D supplements continues. Wherever the balance of pros and cons lies, one benefit that can’t be expected is a reduction in risk of cardiovascular disease. A systematic review of 21 randomised trials that recruited more than 80 000 participants found nothing to suggest that long term vitamin D supplementation leads to any lowering of rates of stroke or myocardial infarction or to a reduction in all cause mortality (JAMA Cardiol doi:10.1001/jamacardio.2019.1870).
Neurofilament light chain
Neurofilament light chain (NfL) is a cytoplasmic protein highly expressed in large diameter myelinated axons. Levels in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.